RecruitingNot ApplicableNCT07237633

Evaluating the Feasibility of a Piezoelectric Smart Sensor as an Aid to Help Clinicians Screen for the Development of Pneumonia in an At-risk Population


Sponsor

National University Hospital, Singapore

Enrollment

50 participants

Start Date

Jan 18, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This proposed research aims to evaluate the feasibility of the piezoelectric sensor as an aid to help clinicians screen for the development of pneumonia in an at-risk population.


Eligibility

Min Age: 21 Years

Inclusion Criteria2

  • Aged 21 years and above
  • Acute stroke patients (i.e. MRI or CT brain findings consistent with diagnosis) or ESRF patients on HD who are mentally competent and cognitively fit to provide consent.

Exclusion Criteria2

  • Individuals who are unable to give informed consent
  • Individuals with active dermatological conditions

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPiezoelectric sensor

The piezoelectric sensor will be applied to the posterior chest wall of all recruited subjects once daily at one time point (excluding weekends, public holidays and discharge day) up to 2 weeks whilst he/she is warded, until pneumonia or fluid overload is detected and confirmed by CXR or the subject is discharged, whichever is earlier.


Locations(1)

National University Hospital

Singapore, Singapore

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07237633


Related Trials